Archive for the Scientific Updates Category

Lancet Gastroenterol Hepatol. 2020 Apr 1. SARS-CoV-2 in wastewater: potential health risk, but also data source. Lodder W1, de Roda Husman AM2. Author information 1 Centre for Infectious Disease Control, National Institute for Public Health and the Environment, 3720 BA Bilthoven, Netherlands. 2 Centre for Infectious Disease Control, National Institute for

J Am Acad Dermatol. 2020 Apr 1. One more paper towel, longer protection. Yu N1, Wu L2, Su J1, Huang K1, Zhao S3, Chen X4. Author information 1 Hunan Engineering Research Center of Skin Health and Disease, Hunan, China; Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan, China; Dermatology Department of Xiangya Hospital

Circulation. 2020 Apr 6. High-Sensitivity Cardiac Troponin Can Be An Ally in the Fight Against COVID-19. Chapman AR1, Bularga A1, Mills NL2. Author information 1 BHF Centre for Cardiovascular Science, University of Edinburgh, United Kingdom. 2 BHF Centre for Cardiovascular Science, University of Edinburgh, United Kingdom; Usher Institute of Population Health

Lancet. 2020 Feb 15;395(10223):507-513. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Chen N1, Zhou M2, Dong X1, Qu J2, Gong F3, Han Y4, Qiu Y5, Wang J3, Liu Y6, Wei Y1, Xia J1, Yu T1, Zhang X7, Zhang L8. Author information 1 Tuberculosis and Respiratory Department, Wuhan Jinyintan Hospital, Wuhan, China. 2

COVID-19 outbreak: less stethoscope, more ultrasound Buonsenso D1, Pata D2, Chiaretti A3. Author information 1 Institute of Pediatrics, Department of Woman and Child Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy; Department of Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy. 2 Institute of Paediatrics, Department

Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Lippi G1, Lavie CJ2, Sanchis-Gomar F3. Author information 1 Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy. 2 John Ochsner Heart and Vascular Institute, Ochsner Clinical School –

  In a rapid response published online by the British Medical Journal, Sommerstein and Gräni1 pushed forward the hypothesis that angiotensin-converting enzyme (ACE) inhibitors (ACE-Is) could act as a potential risk factor for fatal Corona virus disease 2019 (COVID-19) by up-regulating ACE2. This notion was quickly picked up by

BMC Nutr. 2017 May 25;3:45. The effects of 100% wild blueberry (Vaccinium angustifolium) juice consumption on cardiometablic biomarkers: a randomized, placebo-controlled, crossover trial in adults with increased risk for type 2 diabetes. Stote KS1, Sweeney MI2, Kean T2, Baer DJ3, Novotny JA3, Shakerley NL4, Chandrasekaran A4, Carrico PM5, Melendez JA4, Gottschall-Pass KT2. Author information 1 Division of

How Vulnerable Are Patients With Cardiovascular Disease to COVID-19, Flu Complications? Maggie L. Shaw Patients with cardiovascular disease are especially vulnerable to respiratory infections, although uncertainty remains on just what damage COVID-19 can cause in these patients. The flu season is also in full swing, with an

Basic Clin Pharmacol Toxicol. 2020 Mar 11. Implicating endothelial cell senescence to dysfunction in the ageing and diseased brain. Graves SI1, Baker DJ1,2. Author information 1 Departments of Biochemistry and Molecular Biology, Mayo Clinic, 200 1st ST SW, Rochester, MN, 55905, United States. 2 Departments of Pediatric and Adolescent Medicine, Mayo Clinic, 200